Bay Area startup Cortexyme gains a $76M round to back a PhII Alzheimer’s study, with a new target in their sights

From Startup Cortexyme

Link to Full Article: https://www.cortexyme.com/single-post/2018/06/01/Bay-Area-startup-Cortexyme-gains-a-76M-round-to-back-a-PhII-Alzheimer%E2%80%99s-study-with-a-new-target-in-their-sights

With the evidence increasingly weighing in against amyloid beta as the best solo target for Alzheimer’s, a startup out of San Francisco has identified a brand new target and now has a $76 million B round to put it through its first proof-of-concept study. https://endpts.com/bay-area-startup-cortexyme-gains-a-76m-round-to-back-a-phii-alzheimers-study-with-a-new-target-in-their-sights/

Please visit their site for more information: Cortexyme.com

All,Biotechnology,Healthcare News
2018-06-27 05:37:23